YOLFTbeta
00

Shanghai Kehua Bio-Engineering Co Ltd

002022 · SHE · Healthcare / Medical Devices

5.10CNY-0.14 (-2.67%)

Price History

Full chart

Market Stats

Previous Close5.24
Open5.26
Day Range5.08 – 5.26
52-Week Range4.47 – 7.54
Volume5.40M
Market Cap3.25B
P/E (TTM)0.00
Forward P/E30.03
EPS-1.37
Dividend Yield0.00%
Beta0.27
50-Day Avg5.57
200-Day Avg5.72

About

Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of reagents and instruments and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated comprehensive solutions for nucleic acid blood screening. It also provides automatic modular and clinical chemistry analyzers and clinical chemistry reagents test menu; automatic chemiluminescence immunoassay analyzers and CLIA reagents test menu; automatic ELISA microplate readers, ELISA microplate washers, and enzyme-linked immunoassay reagents; and diagnostics kit for HIV and SARS-CoV-2 IgM/IgG antibody, HIV I/II Ab rapid tests, diagnostic kit for Hepatitis B surface antigen and Hepatitis C virus antibody, and diagnostic kit for antibody to T. Palladium. In addition, the company offers molecular diagnostics solutions, including fully automated nucleic acid blood screening laboratory solution and nucleic acid testing and detection kits; automatic multifunctional veterinary analyzer; and mass spectrometry. It exports its products. Further, it provides instrument products, including biochemical diagnostics, immunological diagnostics, molecular diagnostics, point-of-care testing (POCT), and mass spectrometry, advancing towards automation, digitization, and intelligence. The company serves healthcare institutions, blood centers, disease control and prevention centers, and research organizations. Its products are used in clinical diagnostics, blood screening, public health, food safety, and scientific research applications. The company was founded in 1981 and is headquartered in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Ming Li
  • Employees1.87K
  • HeadquartersCaohejing Hi-Tech Park, Shanghai, China, 200233, China
  • Websitehttps://www.skhb.com

Leadership

  • Mr. Ming LiChairman & President · b. 1976
  • Mr. Xian Feng ZangFinancial Director · b. 1975
  • Mr. Baogang MiaoVP & Non-Independent Director · b. 1976
  • Mr. Jiaming LiangVP & Non-Independent Director · b. 1982
  • Ms. Hongying JinVP & Board Secretary · b. 1972
  • Mr. Shin Kang HyukVice President · b. 1967
  • Lei YuAccounting Supervisor

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue131.85M172.92M217.00M239.06M300.57M339.12M399.10M487.12M621.20M781.32M873.89M1.01B1.11B1.22B1.16B1.40B1.59B1.99B2.41B4.16B4.85B6.97B2.43B1.76B1.64B
Growth (%)-+31.15%+25.49%+10.16%+25.73%+12.83%+17.69%+22.05%+27.53%+25.78%+11.85%+16.00%+9.94%+9.28%-5.10%+20.84%+14.14%+24.85%+21.32%+72.11%+16.82%+43.58%-65.16%-27.55%-6.63%
Cost of Revenue41.11M61.21M99.10M101.48M133.37M144.94M156.28M190.22M266.13M359.99M425.18M515.26M571.20M665.54M670.34M820.52M942.98M1.18B1.36B1.77B2.21B3.41B1.48B1.25B1.07B
Gross Profit90.74M111.71M117.90M137.58M167.20M194.17M242.81M296.89M355.06M421.32M448.71M498.42M543.23M552.35M485.45M576.16M651.13M813.36M1.06B2.38B2.65B3.56B944.72M511.95M576.20M
Gross Margin68.82%64.60%54.33%57.55%55.63%57.26%60.84%60.95%57.16%53.92%51.35%49.17%48.75%45.35%42.00%41.25%40.85%40.87%43.86%57.29%54.52%51.14%38.91%29.10%35.08%
Operating Expense44.72M59.62M62.78M71.36M85.67M101.41M105.15M125.26M135.33M177.37M180.37M233.34M213.99M218.65M247.77M319.90M389.77M515.71M726.76M1.02B1.01B1.50B1.12B1.24B913.78M
Operating Income46.02M52.09M55.12M66.22M81.53M92.76M137.66M171.64M219.73M243.96M268.34M265.08M329.24M333.69M237.68M256.26M261.36M297.64M332.25M1.36B1.64B2.07B-179.33M-726.82M-337.58M
Operating Margin34.90%30.12%25.40%27.70%27.13%27.35%34.49%35.24%35.37%31.22%30.71%26.15%29.54%27.40%20.56%18.35%16.40%14.96%13.76%32.66%33.82%29.63%-7.39%-41.32%-20.55%
EBITDA46.14M58.97M64.02M78.29M94.99M106.53M159.28M216.56M259.93M293.82M301.32M325.50M385.24M386.02M290.73M339.14M340.66M398.90M477.01M1.52B1.85B2.27B50.82M-471.03M-549.97M
EBITDA Margin35.00%34.10%29.50%32.75%31.60%31.42%39.91%44.46%41.84%37.61%34.48%32.11%34.57%31.70%25.15%24.28%21.37%20.04%19.76%36.69%38.01%32.58%2.09%-26.78%-33.48%
Net Income26.18M31.88M35.72M42.84M56.43M74.58M118.00M166.08M204.34M225.26M226.75M239.83M288.33M291.97M210.62M232.40M217.76M207.78M202.48M675.36M850.41M971.56M-234.01M-640.60M-732.14M
Net Income Margin19.86%18.44%16.46%17.92%18.77%21.99%29.57%34.09%32.90%28.83%25.95%23.66%25.87%23.97%18.22%16.64%13.66%10.44%8.39%16.25%17.52%13.94%-9.64%-36.41%-44.58%
R&D---------8.31M11.68M39.42M20.78M26.87M33.98M35.23M35.91M42.18M65.66M146.93M148.47M250.49M218.98M242.40M189.62M
R&D as % of Total Revenue---------1.06%1.34%3.89%1.86%2.21%2.94%2.52%2.25%2.12%2.72%3.54%3.06%3.59%9.02%13.78%11.54%
Interest Expense455.27K1.25M571.41K415.19K435.66K820.16K1.50M1.47M2.20M2.88M3.36M2.66M2.23M286.65K04.09M3.96M13.76M27.64M37.24M43.02M42.96M47.06M42.67M23.32M
Interest Expense % of Total Revenue0.35%0.72%0.26%0.17%0.14%0.24%0.38%0.30%0.35%0.37%0.38%0.26%0.20%0.02%0.00%0.29%0.25%0.69%1.14%0.90%0.89%0.62%1.94%2.43%1.42%

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets166.81M225.50M241.23M445.33M457.03M484.49M612.64M737.31M925.84M1.09B1.20B1.29B1.37B1.43B2.07B2.32B2.72B3.50B3.70B5.98B6.96B8.81B6.81B5.24B4.64B
Total Liabilities36.84M79.29M82.31M63.51M76.32M86.46M126.16M93.56M133.03M155.58M175.89M199.05M162.08M161.39M345.97M422.47M636.48M1.07B1.01B2.08B1.82B2.96B1.82B1.25B1.53B
Total Equity81.92M90.26M100.13M333.60M340.78M375.62M459.21M614.66M755.60M899.63M978.69M1.02B1.13B1.26B1.67B1.84B2.00B2.18B2.36B3.14B3.87B4.81B4.03B3.35B2.64B
Cash36.87M59.37M81.20M232.76M182.31M156.28M239.21M331.36M468.36M571.64M587.65M532.23M474.17M380.93M650.58M747.55M689.00M489.92M442.35M2.15B2.64B3.47B1.63B864.63M857.93M
Total Debt-43.00M43.00M15.00M16.77M26.00M33.50M23.00M49.00M58.00M58.00M43.00M--52.73M38.83M51.93M365.54M491.77M1.10B879.80M866.35M847.01M410.11M-
Net Debt-36.87M-16.37M-38.20M-217.76M-165.54M-130.28M-205.71M-308.36M-419.36M-513.64M-529.65M-489.23M-474.17M-380.93M-597.85M-708.72M-637.07M-124.39M49.43M-1.05B-1.76B-2.61B-783.89M-454.52M-

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-41.48M70.57M48.74M73.97M87.21M112.93M137.66M217.51M241.83M219.80M213.74M250.22M249.64M224.30M281.25M130.71M126.79M248.87M1.37B1.08B2.15B-474.89M-50.12M22.44M
Investing Cash Flow--30.38M-14.70M-44.56M-74.78M-80.03M-561.61K-18.66M-37.63M-58.10M-54.72M-54.01M-85.45M-225.22M-165.91M-104.63M-140.62M-578.36M-311.72M-246.17M-212.49M-407.82M-606.42M75.87M-
Financing Cash Flow-11.40M-34.04M147.39M-49.62M-33.19M-29.31M-26.60M-42.85M-79.90M-148.69M-215.20M-222.71M-117.52M206.06M-78.88M-50.44M253.90M16.61M597.96M-555.78M-775.14M-797.23M-774.15M-
Capital Expenditure020.57M24.86M44.69M13.92M25.08M17.81M17.70M41.71M37.92M71.65M72.98M86.37M100.67M85.62M103.25M105.12M123.98M140.21M257.72M216.03M427.91M330.93M254.82M139.29M
Free Cash Flow-20.91M45.71M4.05M60.05M62.13M95.12M119.96M175.80M203.91M148.15M140.77M163.85M148.97M138.68M178.01M25.59M2.81M108.66M1.11B863.19M1.73B-805.82M-304.94M-116.86M
Dividends Paid-37.05M39.08M709.38K59.88M47.36M36.54M11.99M65.32M84.92M151.02M199.55M179.12M113.17M102.55M63.55M71.10M41.76M33.44M33.41M102.78M33.42M318.00M24.44M15.45M
FCF to OCF-50.41%64.78%8.30%81.18%71.25%84.23%87.14%80.83%84.32%67.40%65.86%65.48%59.68%61.83%63.29%19.58%2.21%43.66%81.15%79.98%80.13%169.68%608.46%-520.78%
Dividend Paid to FCF-177.19%85.49%17.53%99.72%76.22%38.42%10.00%37.16%41.65%101.94%141.76%109.32%75.97%73.95%35.70%277.79%1487.50%30.78%3.01%11.91%1.94%-39.46%-8.02%-13.22%

Earnings

Report DateJun 3, 2009Sep 2, 2009Oct 26, 2009Mar 3, 2010Apr 28, 2010Sep 1, 2010Oct 27, 2010Mar 2, 2011Apr 27, 2011Aug 31, 2011Oct 20, 2011Feb 29, 2012Apr 19, 2012Aug 15, 2012Oct 25, 2012Feb 27, 2013Apr 22, 2013Jul 18, 2013Oct 24, 2013Feb 26, 2014Apr 17, 2014Aug 21, 2014Oct 27, 2014Feb 2, 2015Apr 29, 2015Aug 27, 2015Oct 27, 2015Feb 27, 2016Apr 27, 2016Aug 25, 2016Oct 27, 2016Feb 22, 2017Apr 27, 2017Aug 25, 2017Oct 27, 2017Feb 8, 2018Apr 27, 2018Aug 24, 2018Oct 24, 2018Mar 21, 2019Apr 26, 2019Aug 28, 2019Oct 30, 2019Apr 29, 2020Aug 28, 2020Oct 28, 2020Apr 6, 2021Aug 27, 2021Oct 29, 2021Apr 30, 2022Aug 26, 2022Oct 27, 2022Mar 23, 2023Apr 22, 2023Aug 17, 2023Oct 28, 2023Mar 23, 2024Apr 19, 2024Aug 30, 2024Oct 22, 2024May 5, 2025Aug 27, 2025Oct 30, 2025Apr 29, 2026Aug 21, 2026
EPS Estimate--0.12-0.11-0.15-0.13-0.13-0.160.170.14-0.130.160.17-0.170.190.190.150.200.210.210.090.110.130.120.090.120.160.190.070.110.130.100.060.090.130.07----------------------
EPS Actual0.090.110.110.090.110.130.150.080.100.130.160.070.100.130.160.080.130.160.170.090.150.180.180.050.100.150.120.040.100.160.130.060.080.160.110.050.090.170.12-0.030.100.170.14-0.010.280.410.570.260.47-0.020.05-0.021.750.11-0.07-0.08-0.42-0.06-0.05-0.14-0.11-0.16-0.20-0.10-0.11
Surprise---8.33%-0.00%-0.00%--23.08%-23.08%--37.50%-23.53%14.29%-0.00%0.00%0.00%--11.76%-5.26%-5.26%-66.67%-50.00%-28.57%-42.86%-55.56%-9.09%23.08%8.33%-33.33%-33.33%0.00%-42.11%-28.57%-18.18%30.77%20.00%-150.00%11.11%30.77%100.00%----------------------
Timing--Pre-market-After-hours-After-hours-After-hours-After-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours--Pre-market-------After-hours-------

Key Statistics & Ratios

Market Cap3.25B
Enterprise Value3.10B
Trailing P/E0.00
Forward P/E30.03
PEG Ratio3.23
Price / Sales1.93
Price / Book1.28
EPS-1.37
Book Value5.03
Revenue (TTM)1.69B
Gross Profit (TTM)411.76M
EBITDA-443.44M
Profit Margin-41.65%
Operating Margin-9.16%
Return on Equity-24.52%
Return on Assets-8.21%
Shares Outstanding531.40M
Shares Float391.45M
Beta0.27
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.60May 10, 2023
20221×
0.07Jul 19, 2022
20211×
0.20Jul 16, 2021
20201×
0.07Jul 9, 2020
20191×
0.07Jun 20, 2019
20181×
0.07May 25, 2018
20171×
0.14Jun 29, 2017
20161×
0.12Jun 29, 2016
20151×
0.20Jul 7, 2015
20141×
0.23Apr 23, 2014
20131×
0.36Apr 26, 2013
20121×
0.40Apr 24, 2012
20111×
0.30May 12, 2011
20101×
0.17May 27, 2010
20091×
0.13Apr 27, 2009
20081×
0.02Apr 25, 2008
20071×
0.11Apr 16, 2007
20061×
0.08Apr 20, 2006
20051×
0.07Apr 6, 2005

Stock Splits

  • May 27, 201012:10
  • Apr 27, 200913:10
  • Apr 28, 200815:10
  • Apr 16, 200715:10
  • Apr 20, 200617:10
  • Oct 27, 200513.6:10
  • Apr 6, 200512:10